I

InBody Co Ltd
KOSDAQ:041830

Watchlist Manager
InBody Co Ltd
KOSDAQ:041830
Watchlist
Price: 32 500 KRW 2.36% Market Closed
Market Cap: 438.1B KRW

Profitability Summary

InBody Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
InBody Co Ltd

Revenue
217.5B KRW
Cost of Revenue
-47.8B KRW
Gross Profit
169.8B KRW
Operating Expenses
-135.8B KRW
Operating Income
34B KRW
Other Expenses
-3.4B KRW
Net Income
30.6B KRW

Margins Comparison
InBody Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
InBody Co Ltd
KOSDAQ:041830
438.1B KRW
78%
16%
14%
US
Abbott Laboratories
NYSE:ABT
217.3B USD
56%
18%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
206.4B USD
66%
29%
29%
US
Boston Scientific Corp
NYSE:BSX
141.9B USD
69%
19%
14%
US
Stryker Corp
NYSE:SYK
134.6B USD
65%
22%
12%
IE
Medtronic PLC
NYSE:MDT
123.3B USD
66%
19%
14%
DE
Siemens Healthineers AG
XETRA:SHL
50.2B EUR
39%
14%
9%
US
Becton Dickinson and Co
NYSE:BDX
55.6B USD
46%
16%
8%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.6B USD
62%
31%
25%
US
Edwards Lifesciences Corp
NYSE:EW
50.4B USD
78%
28%
23%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.8B USD
41%
14%
11%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
InBody Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
InBody Co Ltd
KOSDAQ:041830
438.1B KRW
12%
10%
12%
14%
US
Abbott Laboratories
NYSE:ABT
217.3B USD
31%
18%
12%
20%
US
Intuitive Surgical Inc
NASDAQ:ISRG
206.4B USD
17%
15%
17%
22%
US
Boston Scientific Corp
NYSE:BSX
141.9B USD
13%
7%
11%
9%
US
Stryker Corp
NYSE:SYK
134.6B USD
14%
6%
14%
12%
IE
Medtronic PLC
NYSE:MDT
123.3B USD
10%
5%
8%
7%
DE
Siemens Healthineers AG
XETRA:SHL
50.2B EUR
12%
5%
10%
6%
US
Becton Dickinson and Co
NYSE:BDX
55.6B USD
7%
3%
7%
6%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.6B USD
65%
31%
58%
35%
US
Edwards Lifesciences Corp
NYSE:EW
50.4B USD
14%
10%
14%
16%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.8B USD
24%
6%
11%
8%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less